Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library
Small-molecule protein kinase inhibitors are used for the treatment of cancer, but off-target effects hinder their clinical use. Especially off-target activation of the pregnane X receptor (PXR) has to be considered, as it not only governs drug metabolism and elimination, but also can promote tumor...
Main Authors: | Enni-Kaisa Mustonen, Tatu Pantsar, Azam Rashidian, Juliander Reiner, Matthias Schwab, Stefan Laufer, Oliver Burk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/8/1299 |
Similar Items
-
Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist
by: Azam Rashidian, et al.
Published: (2022-01-01) -
The role of pregnane X receptor (PXR) in substance metabolism
by: Ye Lv, et al.
Published: (2022-08-01) -
Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites
by: Rajamanikkam Kamaraj, et al.
Published: (2022-09-01) -
Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
by: Aikaterini Skandalaki, et al.
Published: (2021-08-01) -
Marine and Semi-Synthetic Hydroxysteroids as New Scaffolds for Pregnane X Receptor Modulation
by: Valentina Sepe, et al.
Published: (2014-05-01)